Old Web
English
Sign In
Acemap
>
authorDetail
>
Cyra Y Kang
Cyra Y Kang
Northwestern University
Medicine
Oncology
Internal medicine
Cancer
Immunotherapy
4
Papers
7
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Association of HLA class I homozygosity with unfavorable clinical outcomes in patients with non-small cell lung cancer treated with chemo-immunotherapy or immunotherapy as first-line therapy.
2021
Heliyon
Dongyup Lee
Jonghanne Park
Horyun Choi
Gahyun Gim
Sukjoo Cho
Leeseul Kim
Youjin Oh
Cyra Y Kang
Yeseul Kim
Dean Tan
Pedro Viveiros
Young Kwang Chae
Show All
Source
Cite
Save
Citations (0)
Abstract 6659: Response to nivolumab and ipilimumab in microsatellite instability-high (MSI-H) cervical carcinoma with acquired resistance to pembrolizumab
2020
Immunology
Gahyun Gim
Sukjoo Cho
Dongyup Lee
Jonghanne Park
Leeseul Kim
Horyun Choi
Cyra Y Kang
Elena Vagia
Pedro Viveiros
Young Kwang Chae
Show All
Source
Cite
Save
Citations (0)
Overcoming acquired resistance to PD-1 inhibitor with the addition of metformin in small cell lung cancer (SCLC).
2020
Cancer Immunology, Immunotherapy
Yeseul Kim
Elena Vagia
Pedro Viveiros
Cyra Y Kang
Ju Young Lee
Gahyun Gim
Sukjoo Cho
Horyun Choi
Leeseul Kim
Inae Park
Jaeyoun Choi
Young Kwang Chae
Show All
Source
Cite
Save
Citations (7)
Association of HLA class 1 homozygosity with unfavorable clinical outcomes in patients with non-small cell lung cancer (NSCLC) treated with PD-1 inhibitor as first-line therapy.
2020
Journal of Clinical Oncology
Young Kwang Chae
Dongyup Lee
Jonghanne Park
Horyun Choi
Gahyun Gim
Sukjoo Cho
Leeseul Kim
Youjin Oh
Cyra Y Kang
Pedro Viveiros
Show All
Source
Cite
Save
Citations (0)
1